How We Pay for Big Pharma's Malpractice Source: MotherJones.com
The main reason we can't get a health reform bill enacted is because the pharmaceutical and insurance industries aren't happy with their piece of the action.
Swans Commentary: Health Care Profits Of DoomSource: swans.com
While the debate over the details of health care reform continues and the negotiations between the two parties and the lobbyists escalate, the desire of 72% of the populace, according to a recent New York Times poll, for a government-run national health plan remains a dispensable …
Baucus, White House in Deal With Drug IndustrySource: ABC News
The pharmaceutical industry agreed Saturday to spend $80 billion over the next decade improving drug benefits for seniors on Medicare and defraying the cost of President Barack Obama's health care legislation, capping secretive negotiations involving key lawmakers and the White H …
Amy Goodman: Baucus' Raucous CaucusSource: Truthdig
This is beginning to look like a replay of the failed 1993 health-care reform efforts led by then-first lady Hillary Rodham Clinton.
Will the FDA Finally Get Out of Bed With Big Pharma?Source: MotherJones.com
A test case for the new government will be how it deals with the pharmaceutical industry, which rivals the gun manufacturers and tobacco companies for the position of most amoral industry in America.
A Big Hypertension Study, and Its Minimal Impact - NYTimes.comSource: The New York Times
The findings, from one of the biggest clinical trials ever organized by the federal government, promised to save the nation billions of dollars in treating the tens of millions of Americans with hypertension — even if the conclusions did seem to threaten pharmaceutical giants l …
Popular Radio Host Has Drug Company TiesSource: The New York Times
An influential psychiatrist who served as the host of public radio's popular "The Infinite Mind" program earned at least $1.3 million between 2000 and 2007 giving marketing lectures for drug makers, income not mentioned on the program.
Drugmaker ads to target Obama ideaSource: The Washington Times
The nation's largest pharmaceutical lobbying group is preparing a multimillion-dollar public relations campaign to tout the importance of free-market health care and undercut an expected push by the Obama administration for price controls of prescription drugs.
Eli Lilly Settles Zyprexa Case With States for $62 MillionSource: The New York Times
Eli Lilly has agreed to pay $62 million to 33 states to settle claims that it improperly marketed Zyprexa, its top-selling drug, to patients who did not have schizophrenia or bipolar disorder, its only approved uses.
Only one in five trials on cancer treatment gets publishedSource: Guardian Unlimited
What this means is that the system is broken. Right now this figure (20% overall and only 5.9% of industry studies) means that the trials system is giving incorrect results, and billions of dollars are being wasted in the service of industry greed.
New Hints Seen That Red Wine May Slow AgingSource: The New York Times
Red wine may be much more potent than was thought in extending human lifespan, researchers say in a new report that is likely to give impetus to the rapidly growing search for longevity drugs.
Bill Moyers Wastes Time on Farm SubsidiesSource: prospect.org
The U.S. farm price support program is a total mess. It gives the wrong incentives in all sorts of situations and it gives money to many of the wrong people. It would be great if it could be restructured. In fact, it would probably be a net gain if it were just eliminated.
How Not to Win the Fight Against AIDS Source: American.com
In frustration, many global activists are now demanding that developing countries be allowed to revoke the patents on AIDS medications in order to make those medications more readily available.
Breast Beating at the G8 SummitSource: monbiot.com
Look at what is happening, right now, in the Philippines. This country has many problems, but one stands out: just 16% of children between 4 and 5 months old are exclusively breastfed(1).
US approves birth control pill that blocks menstruationSource: New Scientist
A birth control pill that may eliminate a woman's monthly menstrual period has received approval from US drug regulators. [...]
The new contraceptive has potential major side effects such as blood clots and strokes, similar to those of traditional birth control.